The automated blood collection market size has grown rapidly in recent years. It will grow from $1.52 billion in 2025 to $1.8 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to manual blood collection methods, reliance on conventional venipuncture, limited availability of automated systems, growing hospital and diagnostic center procedures, increasing demand for accurate diagnostics.
The automated blood collection market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to technological advancements in robotic venipuncture, rising adoption of point-of-care testing, increased investment in hospital automation, expansion of diagnostic centers and pathology laboratories, regulatory support for automated sample collection. Major trends in the forecast period include rising adoption of automated blood collection devices in hospitals, integration of robotic venipuncture and fingerstick systems, growing use of point-of-care blood collection solutions, increased focus on patient safety and comfort during sampling, expansion of high-precision diagnostics and therapeutic monitoring.
A notable increase in blood donation is expected to propel the growth of the automated blood collection market going forward. Blood donation is increasing due to multiple factors, including heightened awareness of the urgent need for blood in emergency medical situations, extensive blood donation campaigns organized by healthcare organizations and community groups, and advancements in medical technology that enhance the safety and efficiency of the donation process. Automated blood collection supports blood donation by streamlining operations and improving overall efficiency. It reduces the reliance on manual processes, thereby minimizing human error and donor discomfort. For instance, in 2024, NHS Blood and Transplant (NHSBT), a UK-based special health authority serving England and Wales, reported 119,371 new blood donations during the 2023-2024 period, reflecting a slight increase from 119,016 donations in 2022-2023. Therefore, the significant rise in blood donation is driving the growth of the automated blood collection market.
Leading companies operating in the automated blood collection market are developing innovative products incorporating advanced technologies, such as PentaPoint technology, to improve the precision and efficiency of blood collection. PentaPoint technology enables a more controlled and accurate blood collection process by using multiple entry points to reduce discomfort and enhance sample quality. For example, in April 2024, Becton, Dickinson, and Company, a US-based medical company, launched the BD Vacutainer UltraTouch push-button blood collection set in India and the US. This device is designed to minimize patient pain and discomfort during blood collection procedures. It integrates BD RightGauge technology, which uses a thinner needle, along with BD PentaPoint technology to significantly reduce insertion pain. Additionally, BD Push Button Technology lowers the risk of needle-stick injuries by 88%, improving both patient and clinician safety.
In January 2025, GVS S.p.A., an Italy-based manufacturer of filtration solutions for the healthcare and life sciences sectors, acquired Haemonetics’ whole blood assets for $67.8 million. Through this acquisition, GVS seeks to broaden its product portfolio and strengthen its leadership in healthcare filtration by integrating proprietary whole blood collection, processing, and filtration solutions along with manufacturing facilities. Haemonetics is a US-based medical technology company that provides innovative blood and plasma collection, processing, and apheresis solutions aimed at improving patient outcomes and healthcare efficiency.
Major companies operating in the automated blood collection market are Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, CSL Plasma, Quest Diagnostics Incorporated, B. Braun Melsungen AG, Fresenius KABI AG, Grifols S.A., Terumo Corporation, Nipro Medical Corporation, Greiner AG, Bio-Rad Laboratories Inc., ICU Medical Inc., Haemonetics Corporation, SARSTEDT AG & Co. KG, Owen Mumford Ltd., Retractable Technologies Inc., Macopharma, Chengdu Rich Science Industry Co. Ltd., Babson Diagnostics, Venibot.
North America was the largest region in the automated blood collection market in 2025. The regions covered in the automated blood collection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated blood collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the automated blood collection market by increasing the cost of imported robotic and high-precision blood collection devices, affecting both production and end-user pricing. Segments such as robotic venipuncture systems and point-of-care fingerstick devices are most affected, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs increase operational costs, they also encourage local manufacturing, innovation in automation technologies, and development of cost-efficient domestic solutions.
The automated blood collection market research report is one of a series of new reports that provides automated blood collection market statistics, including automated blood collection industry global market size, regional shares, competitors with a automated blood collection market share, detailed automated blood collection market segments, market trends and opportunities, and any further data you may need to thrive in the automated blood collection industry. This automated blood collection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated blood collection refers to the use of advanced systems that collect blood samples efficiently and precisely. These systems reduce manual handling, improve accuracy, minimize errors, and enhance patient comfort and safety, making them valuable in laboratories and healthcare facilities.
The primary categories in the automated blood collection market include arterial sampling, venipuncture sampling, and fingerstick sampling. Arterial sampling involves drawing blood from an artery, commonly the radial or femoral artery, to obtain samples for diagnostic purposes. The applications include diagnostics, treatment, and therapeutic procedures. The various end users include hospitals, diagnostic centers, pathology laboratories, and others.
The automated blood collection market consists of revenues earned by entities by providing services such as maintenance services, calibration, and technical support for their machines. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated blood collection market also includes sales of collection bags, needles, tubing sets, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated blood collection market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to technological advancements in robotic venipuncture, rising adoption of point-of-care testing, increased investment in hospital automation, expansion of diagnostic centers and pathology laboratories, regulatory support for automated sample collection. Major trends in the forecast period include rising adoption of automated blood collection devices in hospitals, integration of robotic venipuncture and fingerstick systems, growing use of point-of-care blood collection solutions, increased focus on patient safety and comfort during sampling, expansion of high-precision diagnostics and therapeutic monitoring.
A notable increase in blood donation is expected to propel the growth of the automated blood collection market going forward. Blood donation is increasing due to multiple factors, including heightened awareness of the urgent need for blood in emergency medical situations, extensive blood donation campaigns organized by healthcare organizations and community groups, and advancements in medical technology that enhance the safety and efficiency of the donation process. Automated blood collection supports blood donation by streamlining operations and improving overall efficiency. It reduces the reliance on manual processes, thereby minimizing human error and donor discomfort. For instance, in 2024, NHS Blood and Transplant (NHSBT), a UK-based special health authority serving England and Wales, reported 119,371 new blood donations during the 2023-2024 period, reflecting a slight increase from 119,016 donations in 2022-2023. Therefore, the significant rise in blood donation is driving the growth of the automated blood collection market.
Leading companies operating in the automated blood collection market are developing innovative products incorporating advanced technologies, such as PentaPoint technology, to improve the precision and efficiency of blood collection. PentaPoint technology enables a more controlled and accurate blood collection process by using multiple entry points to reduce discomfort and enhance sample quality. For example, in April 2024, Becton, Dickinson, and Company, a US-based medical company, launched the BD Vacutainer UltraTouch push-button blood collection set in India and the US. This device is designed to minimize patient pain and discomfort during blood collection procedures. It integrates BD RightGauge technology, which uses a thinner needle, along with BD PentaPoint technology to significantly reduce insertion pain. Additionally, BD Push Button Technology lowers the risk of needle-stick injuries by 88%, improving both patient and clinician safety.
In January 2025, GVS S.p.A., an Italy-based manufacturer of filtration solutions for the healthcare and life sciences sectors, acquired Haemonetics’ whole blood assets for $67.8 million. Through this acquisition, GVS seeks to broaden its product portfolio and strengthen its leadership in healthcare filtration by integrating proprietary whole blood collection, processing, and filtration solutions along with manufacturing facilities. Haemonetics is a US-based medical technology company that provides innovative blood and plasma collection, processing, and apheresis solutions aimed at improving patient outcomes and healthcare efficiency.
Major companies operating in the automated blood collection market are Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, CSL Plasma, Quest Diagnostics Incorporated, B. Braun Melsungen AG, Fresenius KABI AG, Grifols S.A., Terumo Corporation, Nipro Medical Corporation, Greiner AG, Bio-Rad Laboratories Inc., ICU Medical Inc., Haemonetics Corporation, SARSTEDT AG & Co. KG, Owen Mumford Ltd., Retractable Technologies Inc., Macopharma, Chengdu Rich Science Industry Co. Ltd., Babson Diagnostics, Venibot.
North America was the largest region in the automated blood collection market in 2025. The regions covered in the automated blood collection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated blood collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the automated blood collection market by increasing the cost of imported robotic and high-precision blood collection devices, affecting both production and end-user pricing. Segments such as robotic venipuncture systems and point-of-care fingerstick devices are most affected, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs increase operational costs, they also encourage local manufacturing, innovation in automation technologies, and development of cost-efficient domestic solutions.
The automated blood collection market research report is one of a series of new reports that provides automated blood collection market statistics, including automated blood collection industry global market size, regional shares, competitors with a automated blood collection market share, detailed automated blood collection market segments, market trends and opportunities, and any further data you may need to thrive in the automated blood collection industry. This automated blood collection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated blood collection refers to the use of advanced systems that collect blood samples efficiently and precisely. These systems reduce manual handling, improve accuracy, minimize errors, and enhance patient comfort and safety, making them valuable in laboratories and healthcare facilities.
The primary categories in the automated blood collection market include arterial sampling, venipuncture sampling, and fingerstick sampling. Arterial sampling involves drawing blood from an artery, commonly the radial or femoral artery, to obtain samples for diagnostic purposes. The applications include diagnostics, treatment, and therapeutic procedures. The various end users include hospitals, diagnostic centers, pathology laboratories, and others.
The automated blood collection market consists of revenues earned by entities by providing services such as maintenance services, calibration, and technical support for their machines. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated blood collection market also includes sales of collection bags, needles, tubing sets, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Blood Collection Market Characteristics
3. Automated Blood Collection Market Supply Chain Analysis
4. Global Automated Blood Collection Market Trends and Strategies
5. Automated Blood Collection Market Analysis of End Use Industries
7. Global Automated Blood Collection Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Blood Collection Total Addressable Market (TAM) Analysis for the Market
9. Automated Blood Collection Market Segmentation
10. Automated Blood Collection Market Regional and Country Analysis
11. Asia-Pacific Automated Blood Collection Market
12. China Automated Blood Collection Market
13. India Automated Blood Collection Market
14. Japan Automated Blood Collection Market
15. Australia Automated Blood Collection Market
16. Indonesia Automated Blood Collection Market
17. South Korea Automated Blood Collection Market
18. Taiwan Automated Blood Collection Market
19. South East Asia Automated Blood Collection Market
20. Western Europe Automated Blood Collection Market
21. UK Automated Blood Collection Market
22. Germany Automated Blood Collection Market
23. France Automated Blood Collection Market
24. Italy Automated Blood Collection Market
25. Spain Automated Blood Collection Market
26. Eastern Europe Automated Blood Collection Market
27. Russia Automated Blood Collection Market
28. North America Automated Blood Collection Market
29. USA Automated Blood Collection Market
30. Canada Automated Blood Collection Market
31. South America Automated Blood Collection Market
32. Brazil Automated Blood Collection Market
33. Middle East Automated Blood Collection Market
34. Africa Automated Blood Collection Market
36. Automated Blood Collection Market Competitive Landscape and Company Profiles
37. Automated Blood Collection Market Other Major and Innovative Companies
40. Automated Blood Collection Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automated Blood Collection Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated blood collection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated blood collection? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated blood collection market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Arterial Sampling; Venipuncture Sampling; Fingerstick Sampling2) By Application: Diagnostics; Treatment; Therapeutics
3) By End-Use: Hospitals; Diagnostic Centers; Pathology Laboratories; Other End-Uses
Subsegments:
1) By Arterial Sampling: Automated Arterial Blood Gas Collection Systems; Closed-Loop Arterial Sampling Systems; Point-of-Care Arterial Sampling Devices; Continuous Arterial Sampling Systems2) By Venipuncture Sampling: Automated Venipuncture Collection Devices; Robotic Venipuncture Systems; High-Precision Venipuncture Blood Collection Systems; Automated Venipuncture Systems for Plasma Or Serum
3) By Fingerstick Sampling: Automated Fingerstick Blood Collection Devices; Portable Fingerstick Collection Devices; Fingerstick Collection Systems for Point-of-Care Testing; Miniaturized Automated Fingerstick Collection Systems
Companies Mentioned: Abbott Laboratories; Siemens Healthineers; Becton Dickinson and Company; CSL Plasma; Quest Diagnostics Incorporated; B. Braun Melsungen AG; Fresenius KABI AG; Grifols S.A.; Terumo Corporation; Nipro Medical Corporation; Greiner AG; Bio-Rad Laboratories Inc.; ICU Medical Inc.; Haemonetics Corporation; SARSTEDT AG & Co. KG; Owen Mumford Ltd.; Retractable Technologies Inc.; Macopharma; Chengdu Rich Science Industry Co. Ltd.; Babson Diagnostics; Venibot
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Blood Collection market report include:- Abbott Laboratories
- Siemens Healthineers
- Becton Dickinson and Company
- CSL Plasma
- Quest Diagnostics Incorporated
- B. Braun Melsungen AG
- Fresenius KABI AG
- Grifols S.A.
- Terumo Corporation
- Nipro Medical Corporation
- Greiner AG
- Bio-Rad Laboratories Inc.
- ICU Medical Inc.
- Haemonetics Corporation
- SARSTEDT AG & Co. KG
- Owen Mumford Ltd.
- Retractable Technologies Inc.
- Macopharma
- Chengdu Rich Science Industry Co. Ltd.
- Babson Diagnostics
- Venibot
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.8 Billion |
| Forecasted Market Value ( USD | $ 3.46 Billion |
| Compound Annual Growth Rate | 17.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
